Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia.

Moore AG, Young H, Keller JM, Ojo LR, Yan J, Simas TA, Maynard SE.

J Matern Fetal Neonatal Med. 2012 Dec;25(12):2651-7. doi: 10.3109/14767058.2012.713055. Epub 2012 Aug 22.

PMID:
22861812
2.

KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.

Salahuddin S, Wenger JB, Zhang D, Thadhani R, Karumanchi SA, Rana S.

Hypertens Pregnancy. 2016 Aug;35(3):330-45. doi: 10.3109/10641955.2016.1148162. Epub 2016 Mar 30.

PMID:
27028795
3.

[Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].

Stepan H, Jank A.

Z Geburtshilfe Neonatol. 2009 Jun;213(3):101-5. doi: 10.1055/s-0029-1224142. Epub 2009 Jun 17. Review. German.

PMID:
19536710
4.

Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.

Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.

J Matern Fetal Neonatal Med. 2014 Jul;27(10):1038-48. doi: 10.3109/14767058.2013.847415. Epub 2013 Oct 29.

PMID:
24066977
5.

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.

Rana S, Cerdeira AS, Wenger J, Salahuddin S, Lim KH, Ralston SJ, Thadhani RI, Karumanchi SA.

PLoS One. 2012;7(10):e48259. doi: 10.1371/journal.pone.0048259. Epub 2012 Oct 26.

6.

PP059. Angiogenic factors and risk of preeclampsia related adverse outcomes in twin pregnancies.

Rana S, Hacker M, Merport A, Salahuddin S, Verlohren S, Perschel F, Karumanchi SA.

Pregnancy Hypertens. 2012 Jul;2(3):273-4. doi: 10.1016/j.preghy.2012.04.170. Epub 2012 Jun 13.

PMID:
26105382
7.

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 11;5(10):e13263. doi: 10.1371/journal.pone.0013263.

8.

Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.

Chaiworapongsa T, Romero R, Korzeniewski SJ, Cortez JM, Pappas A, Tarca AL, Chaemsaithong P, Dong Z, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2014 Jan;27(2):132-44. doi: 10.3109/14767058.2013.806905. Epub 2013 Aug 8.

9.

Angiogenic factors and preeclampsia.

Steinberg G, Khankin EV, Karumanchi SA.

Thromb Res. 2009;123 Suppl 2:S93-9. doi: 10.1016/S0049-3848(09)70020-9. Review.

PMID:
19217486
10.

Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.

Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H.

BMC Pregnancy Childbirth. 2014 Sep 18;14:324. doi: 10.1186/1471-2393-14-324.

11.

Angiogenic factors for the prediction of preeclampsia in high-risk women.

Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE.

Am J Obstet Gynecol. 2007 Sep;197(3):244.e1-8.

PMID:
17826405
12.

[Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].

Husse S, Gottschlich A, Schrey S, Stepan H, Hoffmann J.

Z Geburtshilfe Neonatol. 2014 Feb;218(1):34-41. doi: 10.1055/s-0034-1368713. Epub 2014 Mar 4. German.

PMID:
24595913
13.

Angiogenic factors and preeclampsia.

Tjoa ML, Levine RJ, Karumanchi SA.

Front Biosci. 2007 Jan 1;12:2395-402. Review.

PMID:
17127249
14.

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.

Rana S, Powe CE, Salahuddin S, Verlohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA.

Circulation. 2012 Feb 21;125(7):911-9. doi: 10.1161/CIRCULATIONAHA.111.054361. Epub 2012 Jan 18.

15.

Serum heat shock protein 70 levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in women with preeclampsia.

Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J Jr.

Clin Chim Acta. 2011 Oct 9;412(21-22):1957-62. doi: 10.1016/j.cca.2011.06.042. Epub 2011 Jul 6.

PMID:
21756887
16.

Soluble endoglin for the prediction of preeclampsia in a high risk cohort.

Maynard SE, Moore Simas TA, Bur L, Crawford SL, Solitro MJ, Meyer BA.

Hypertens Pregnancy. 2010;29(3):330-41. doi: 10.3109/10641950902968684.

PMID:
20670156
17.

Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.

Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M.

Hypertens Pregnancy. 2009 Feb;28(1):95-108. doi: 10.1080/10641950802419895.

PMID:
19165674
18.

Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies.

Troisi R, Braekke K, Harsem NK, Hyer M, Hoover RN, Staff AC.

Am J Obstet Gynecol. 2008 Dec;199(6):653.e1-10. doi: 10.1016/j.ajog.2008.06.030. Epub 2008 Aug 22.

19.

The use of angiogenic factors in discriminating preeclampsia: are they ready for prime time?

Srinivas SK, Larkin J, Sammel MD, Appleby D, Bastek J, Andrela CM, Ofori E, Elovitz MA.

J Matern Fetal Neonatal Med. 2010 Nov;23(11):1294-300. doi: 10.3109/14767051003677988.

PMID:
20482287
20.

Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.

Rana S, Schnettler WT, Powe C, Wenger J, Salahuddin S, Cerdeira AS, Verlohren S, Perschel FH, Arany Z, Lim KH, Thadhani R, Karumanchi SA.

Hypertens Pregnancy. 2013 May;32(2):189-201. doi: 10.3109/10641955.2013.784788.

Supplemental Content

Support Center